100 related articles for article (PubMed ID: 722081)
1. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
Huber SA; Bigi G; Lucas ZJ
Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
[TBL] [Abstract][Full Text] [Related]
3. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
[TBL] [Abstract][Full Text] [Related]
4. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
[No Abstract] [Full Text] [Related]
5. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
Huber SA; Lucas ZJ
J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
[No Abstract] [Full Text] [Related]
6. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
Kuperman O; Fortner GW; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
[TBL] [Abstract][Full Text] [Related]
7. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
Christensen ND; Kreider JW; Horetsky RL
Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
[TBL] [Abstract][Full Text] [Related]
8. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
Fortner GW; Kuperman O; Lucas ZJ
J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
[TBL] [Abstract][Full Text] [Related]
9. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo.
Haskill JS; Fett JW
J Immunol; 1976 Nov; 117(5 Pt.2):1992-8. PubMed ID: 993593
[TBL] [Abstract][Full Text] [Related]
10. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
11. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
12. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.
Blair PB; Lane MA; Mar P
J Immunol; 1976 Mar; 116(3):606-9. PubMed ID: 176266
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
Hoon DB; Ziola B; Ramshaw I
Cancer Res; 1984 Jun; 44(6):2406-9. PubMed ID: 6722781
[TBL] [Abstract][Full Text] [Related]
14. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
Boyer CM; Kreider JW; Bartlett GL
Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
[TBL] [Abstract][Full Text] [Related]
15. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
[No Abstract] [Full Text] [Related]
16. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL
J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
[TBL] [Abstract][Full Text] [Related]
17. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
DeLustro F; Haskill JS
J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
19. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat.
Quan N; Zhang Z; Demetrikopoulos MK; Kitson RP; Chambers WH; Goldfarb RH; Weiss JM
Cancer Res; 1999 Mar; 59(5):1080-9. PubMed ID: 10070966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
